ストックスクリーナーアプリを入手
0.9801
2.96%
-0.0299
前日終値:
$1.01
開ける：
$1.01
24時間の取引高:
209.99K
Relative Volume:
0.52
時価総額：
$47.63M
収益：
$1.14M
当期純損益:
$-56.27M
株価収益率:
-0.8074
EPS:
-1.2139
ネットキャッシュフロー:
$-51.94M
1週間 パフォーマンス:
+0.01%
1か月 パフォーマンス:
-0.94%
6か月 パフォーマンス:
+13.95%
1年 パフォーマンス:
-37.57%
1日の値動き範囲:
$0.9801
$1.03
1週間の範囲:
$0.9792
$1.09
52週間の値動き範囲:
$0.27
$1.83
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
名前
Werewolf Therapeutics Inc
セクター
電話
617-952-0555
住所
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, MRNA, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.9801 | 47.63M | 1.14M | -56.27M | -51.94M | -1.2139 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-19 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-04-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-24 | 開始されました | Wedbush | Outperform |
| 2023-06-06 | 再開されました | Jefferies | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-25 | 開始されました | Evercore ISI | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-25 | 開始されました | Jefferies | Buy |
| 2021-05-25 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Werewolf Therapeutics Inc (HOWL) 最新ニュース
Cocrystal Pharma, Inc. (COCP) Stock Price & News - Syfe
AEON Biopharma, Inc. (AEON) Stock Price & News - Syfe
QNRX Stock Price, Quote & News - Syfe
Theriva Biologics, Inc. (TOVX) Stock Price & News - Syfe
Werewolf Therapeutics, Inc. (HOWL) Stock Price, News, Quote & History - Yahoo! Finance Canada
KRYS Reports Positive Early Data for KB113 in Gorlin Syndrome - Zacks Investment Research
Lite Strategy, Inc. (LITS) Stock Price & News - Syfe
Valion Bio, Inc. (VBIO) Stock Price & News - Syfe
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why - Zacks Investment Research
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - Zacks Investment Research
Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases - Zacks Investment Research
New Strong Buy Stocks for October 9th - Zacks Investment Research
Marker Therapeutics, Inc. (MRKR) Stock Price & News - Syfe
Scienture Holdings, Inc. (SCNX) Stock Price & News - Syfe
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. ( - mykxlg.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. ( - True North Radio Network
Kairos Pharma, Ltd. (KAPA) Stock Price & News - Syfe
Ambros deal would give Werewolf (NASDAQ: HOWL) investors rights to future sales of legacy drug assets - Stock Titan
German investor discloses stake in Werewolf Therapeutics (NASDAQ: HOWL) - Stock Titan
Werewolf Therapeutics (HOWL) Dips 1.43% to $0.97 as Tight Trading Range Sends Stock Toward Key SupportEarnings Miss Risk - dars.gov.et
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
CalciMedica, Inc. (CALC) Stock Price & News - Syfe
Werewolf Therapeutics Stock Price Forecast. Should You Buy HOWL? - StockInvest.us
Werewolf Therapeutics stock gains on merger scrutiny and trial progress - ad-hoc-news.de
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Lantern Pharma Inc. (LTRN) Stock Price & News - Syfe
Actuate Therapeutics, Inc. (ACTU) Stock Price & News - Syfe
Onconetix, Inc. (ONCO) Stock Price & News - syfe.com
BioXcel Therapeutics, Inc. (BTAI) Stock Price & News - Syfe
Valion Bio, Inc. (VBIO) Stock Price & News - Syfe
Werewolf Therapeutics Completes Key Early Trial For WTX-124 In Hard-To-Treat Cancers - TipRanks
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the MergerHOWL, HZO, TYFG and FULC - Sahm
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Werewolf, Ambros to Merge in All-Stock Deal - Contract Pharma
HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders - The Daily Tribune News
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the MergerHOWL, HZO, TYFG and FULC - PR Newswire
Werewolf Therapeutics And Ambros Therapeutics Merge With $150 Million PIPE To Advance Phase III CRPS Drug Neridronate - Pulse 2.0
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the MergerHOWL, HZO, TYFG and FULC - Morningstar
Werewolf (HOWL) Outlook: Moves 102.57% Up to $0.87 in the Latest Reading; Boundary Watch: $0.83 and $0.91 Define the Nearby Reference Levels at the CloseMoving Average Ribbon - vinanet.vn
Werewolf (HOWL) Outlook: Moves 102.57% Up to $0.87 in the Latest Reading; Boundary Watch: $0.83 and $0.91 Define the Nearby Reference Levels at the CloseMESA MA - siam.in
HOWL | Werewolf Therapeutics, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Ambros Therapeutics to merge with Werewolf Therapeutics in all-stock deal - Dealroom
Werewolf Therapeutics (NASDAQ:HOWL) Deal Changes Pipeline Focus - Kalkine Media
Werewolf Therapeutics Shares Surge Twofold After Ambros Merger, Investors Retain 6.8% Stake - TechStock²
Latham Watkins Advises on Oversubscribed Private Placement in Werewolf Ambros Merger Transaction - Latham & Watkins LLP
Werewolf Therapeutics, Inc. announced that it expects to receive $150 million in funding - marketscreener.com
Werewolf Therapeutics Strikes Reverse Merger With Ambros, Secures $150 Million for Rare Pain Drug - finance.biggo.com
Trending Stocks Today | Werewolf Therapeutics Shoots up 117.27% - Moomoo
Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News - Yahoo Finance
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Werewolf Therapeutics Inc (HOWL) 財務データ
収益
当期純利益
現金流量
EPS
Werewolf Therapeutics Inc (HOWL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| EVNIN LUKE | Director |
Jul 06 '26 |
Sale |
0.32 |
35,770 |
11,446 |
107,429 |
| MPM BioVentures 2014, L.P. | Shareholder |
Jul 06 '26 |
Proposed Sale |
0.34 |
96,873 |
32,976 |
0 |
| MPM BioVentures 2014 (B), L.P. | Shareholder |
Jul 06 '26 |
Proposed Sale |
0.34 |
6,459 |
2,199 |
0 |
| UBS Oncology Impact Fund, L.P. | Shareholder |
Jul 06 '26 |
Proposed Sale |
0.34 |
80,142 |
27,280 |
0 |
| MPM Asset Management LLC | Shareholder |
Jul 06 '26 |
Proposed Sale |
0.34 |
15,341 |
5,222 |
0 |
| MPM Asset Management Investors | Shareholder |
Jul 06 '26 |
Proposed Sale |
0.34 |
3,332 |
1,134 |
0 |
| MPM Oncology Innovations Fund, | Shareholder |
Jul 06 '26 |
Proposed Sale |
0.34 |
21,194 |
7,214 |
0 |
| MPM BioVentures 2014 (B), L.P. | Shareholder |
Jun 29 '26 |
Proposed Sale |
0.32 |
7,087 |
2,289 |
0 |
| MPM Asset Management LLC | Shareholder |
Jun 29 '26 |
Proposed Sale |
0.32 |
16,830 |
5,436 |
0 |
| MPM Oncology Innovations Fund, | Shareholder |
Jun 29 '26 |
Proposed Sale |
0.32 |
23,248 |
7,509 |
0 |
3.09%
0.72%
大文字化:
|
ボリューム (24 時間):